The use of real-world evidence can prevent pharma companies from performing studies based on flawed data.
Dr. Samy Suissa and Dr. Meg Richards
Advertisement
Articles by Dr. Samy Suissa and Dr. Meg Richards
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
3
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
4
US Funding for Global Vaccine Group Dependent on Thimerosal Removal
5